A detailed history of Mason & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mason & Associates Inc holds 14,855 shares of PFE stock, worth $383,704. This represents 0.11% of its overall portfolio holdings.

Number of Shares
14,855
Previous 14,945 0.6%
Holding current value
$383,704
Previous $418,000 2.63%
% of portfolio
0.11%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$27.7 - $31.39 $2,493 - $2,825
-90 Reduced 0.6%
14,855 $429,000
Q1 2024

Apr 23, 2024

BUY
$25.89 - $29.73 $386,926 - $444,314
14,945 New
14,945 $414,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mason & Associates Inc Portfolio

Follow Mason & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mason & Associates Inc with notifications on news.